maklogo
Market Research Report

Global Abdominal Vascular Graft Market Insights, Size, and Forecast By End Use (Hospitals, Ambulatory Surgical Centers, Specialized Clinics), By Material (Polyester, Polytetrafluoroethylene, Composite Materials), By Application (Aneurysm Repair, Vascular Bypass, Trauma Surgery), By Type (Endovascular Grafts, Surgical Grafts, Fenestrated Grafts), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:61833
Published Date:Jan 2026
No. of Pages:211
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global Abdominal Vascular Graft Market is projected to grow from USD 2.85 Billion in 2025 to USD 5.12 Billion by 2035, reflecting a compound annual growth rate of 6.7% from 2026 through 2035. The abdominal vascular graft market encompasses medical devices used to repair or replace damaged or diseased abdominal arteries, primarily for treating conditions like aneurysms and occlusive diseases. These grafts provide a conduit for blood flow, restoring arterial integrity and preventing life-threatening complications. The market is driven by several key factors, including the increasing global prevalence of cardiovascular diseases, a growing geriatric population more susceptible to abdominal aortic conditions, and advancements in surgical techniques, particularly minimally invasive endovascular aneurysm repair EVAR. Furthermore, rising awareness about early diagnosis and treatment of vascular disorders contributes significantly to market expansion. The dominant segment, Aneurysm Repair, underscores the critical need for effective solutions for abdominal aortic aneurysms, a life-threatening condition.

Global Abdominal Vascular Graft Market Value (USD Billion) Analysis, 2025-2035

maklogo
6.7%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

Important trends shaping the market include the continued shift towards minimally invasive procedures, offering reduced patient recovery times and improved outcomes. Technological innovations in graft materials, design, and delivery systems are also crucial, leading to more durable and biocompatible grafts. However, the market faces restraints such as the high cost associated with these devices and surgical procedures, reimbursement challenges in some regions, and the potential for complications after graft implantation. Stringent regulatory approval processes for new devices also pose a hurdle for manufacturers. Despite these challenges, significant opportunities exist in developing advanced biomaterials, personalized grafts, and expanding market access in emerging economies with improving healthcare infrastructure. The increasing adoption of hybrid operating rooms and advanced imaging technologies further supports market growth by enhancing procedural precision and safety.

North America leads the market due to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and significant investment in research and development of innovative vascular technologies. A strong presence of key market players and favorable reimbursement policies also contribute to its dominance. Asia Pacific is poised to be the fastest-growing region, driven by its large and aging population, improving healthcare access, increasing healthcare expenditure, and a rising awareness of vascular health. Key players like Cardinal Health, Endologix, JOTEC, Cook Medical, Bard Medical, Aptus Endosystems, Gore Medical, Boston Scientific, Vasorum, and Terumo Corporation are actively pursuing strategies such as product innovation, strategic collaborations, and geographical expansion to strengthen their market positions. Their focus is on developing next-generation grafts with enhanced durability and ease of implantation, along with expanding their distribution networks to reach a wider patient base globally.

Quick Stats

  • Market Size (2025):

    USD 2.85 Billion

  • Projected Market Size (2035):

    USD 5.12 Billion

  • Leading Segment:

    Aneurysm Repair (62.8% Share)

  • Dominant Region (2025):

    North America (38.7% Share)

  • CAGR (2026-2035):

    6.7%

What is Abdominal Vascular Graft?

An Abdominal Vascular Graft is a surgical procedure to replace or bypass a diseased or blocked major blood vessel in the abdomen, typically the aorta or iliac arteries. The graft is a synthetic tube, often made of Dacron or ePTFE, or occasionally a vein from the patient. Its purpose is to restore proper blood flow to the lower extremities and abdominal organs, preventing complications like aneurysm rupture or limb ischemia. This intervention is crucial for treating conditions such as abdominal aortic aneurysms, aortoiliac occlusive disease, and some types of vascular trauma, improving patient quality of life and preventing life-threatening events by reestablishing a healthy circulatory pathway.

What are the Trends in Global Abdominal Vascular Graft Market

  • Bioengineered Grafts Reshaping Abdominal Aortic Repair

  • Robotic Assisted Procedures Driving Graft Adoption

  • Personalized Medicine Revolutionizing Graft Selection

  • Minimally Invasive Approaches Expanding Market Reach

  • Smart Grafts Enhancing Post Operative Surveillance

Bioengineered Grafts Reshaping Abdominal Aortic Repair

Bioengineered grafts are transforming abdominal aortic repair by offering enhanced biological integration and reduced long term complications compared to synthetic alternatives. These innovative grafts often incorporate native tissue components or utilize advanced materials designed to promote cell adhesion and neovascularization. This fosters better healing, reduces the risk of infection, and potentially minimizes the need for reintervention. Their superior biocompatibility and mimicry of natural vessel mechanics lead to improved patient outcomes and durability, particularly for complex anatomies or younger patients. This trend signifies a shift towards more physiologically compatible and patient specific solutions in the global abdominal vascular graft market, ultimately improving the effectiveness and longevity of aortic repairs.

Robotic Assisted Procedures Driving Graft Adoption

Robotic assisted procedures are increasingly influencing abdominal vascular graft adoption. Surgeons leveraging robotic platforms gain enhanced precision and dexterity during complex graft implantation. This improved control allows for more meticulous anastomoses and better placement, particularly in challenging anatomical locations. The sophisticated imaging and tremor filtration offered by robotics lead to superior outcomes and fewer complications. Consequently, there is a growing demand for grafts optimized for robotic delivery and placement, driving innovation in graft design and materials. Manufacturers are focusing on grafts that are easier to manipulate and deploy robotically, ensuring a perfect fit and long term patency. This synergy between advanced surgical robotics and innovative graft technology is a key factor in the expanding utilization of abdominal vascular grafts.

What are the Key Drivers Shaping the Global Abdominal Vascular Graft Market

  • Rising Incidence of Abdominal Aortic Aneurysms (AAAs)

  • Technological Advancements in Graft Materials and Delivery Systems

  • Growing Geriatric Population and Associated Vascular Diseases

  • Increasing Demand for Minimally Invasive Endovascular Procedures (EVAR/TEVAR)

  • Expansion of Healthcare Infrastructure and Reimbursement Policies

Rising Incidence of Abdominal Aortic Aneurysms (AAAs)

The increasing occurrence of abdominal aortic aneurysms significantly fuels the global abdominal vascular graft market. This upward trend in AAA diagnoses stems from several factors, including an aging global population and a higher prevalence of associated risk factors such as smoking, hypertension, and atherosclerosis. As more individuals develop AAAs, the demand for effective treatment options naturally rises. Abdominal vascular grafts are crucial for repairing or replacing weakened aortic sections, preventing rupture and life threatening complications. The imperative to manage these growing patient numbers and provide durable solutions directly translates into increased adoption of these specialized grafts. Healthcare providers are performing more elective and emergency repair procedures, driving sustained growth in the market.

Technological Advancements in Graft Materials and Delivery Systems

Technological advancements are profoundly shaping the global abdominal vascular graft market. Innovations in graft materials are leading to enhanced biocompatibility, reduced immune response, and improved long term patency. Researchers are developing new synthetic polymers and biomimetic composites that mimic natural vessel properties, promoting better cell integration and minimizing complications like thrombosis and infection.

Concurrently, sophisticated delivery systems are emerging, enabling less invasive implantation techniques. These include steerable catheters and expandable grafts, facilitating precise placement through smaller incisions. Such advancements reduce patient recovery times and enhance procedural safety. The continued evolution in material science and minimally invasive delivery technologies is a critical driver for market growth, addressing unmet clinical needs and expanding the treatable patient population.

Growing Geriatric Population and Associated Vascular Diseases

An aging global populace significantly drives the abdominal vascular graft market. As individuals live longer, they become more susceptible to age related vascular conditions such as abdominal aortic aneurysms and peripheral artery disease. These conditions frequently require surgical intervention to prevent life threatening complications like rupture or limb loss. Abdominal vascular grafts provide a crucial solution, replacing diseased segments of blood vessels and restoring proper blood flow. The increasing prevalence of these age related diseases directly translates into a higher demand for grafts, pushing market growth as healthcare systems cater to the needs of a continually expanding geriatric demographic.

Global Abdominal Vascular Graft Market Restraints

Stringent Regulatory Approval Processes for Novel Graft Technologies

Rigorous regulatory approval processes for novel graft technologies represent a significant restraint in the global abdominal vascular graft market. Developing innovative graft solutions, particularly those involving new materials, designs, or biological components, necessitates extensive preclinical testing, costly clinical trials across multiple phases, and a meticulous data submission to regulatory bodies. This protracted evaluation period from initial concept to market authorization often spans many years, delaying patient access to potentially superior treatments. The high financial investment required for these trials, coupled with the inherent risk of non approval, disincentivizes smaller companies and limits research and development expenditure by larger players. Consequently, the introduction of groundbreaking graft technologies is slowed, hindering market innovation and potentially restricting the growth of the overall market.

High Cost and Reimbursement Challenges for Advanced Graft Solutions

Advanced graft solutions for abdominal vascular repair, while offering superior patient outcomes, face significant adoption hurdles due to their high production costs. These expenses translate into elevated prices for healthcare providers, impacting their budgets and often making more traditional, less expensive grafts a more financially viable option. Furthermore, reimbursement policies from insurance providers and government healthcare programs often do not fully cover the premium cost of these innovative grafts. This creates a financial disincentive for hospitals and surgeons to utilize advanced solutions, despite their clinical benefits. The gap between the actual cost of these cutting-edge grafts and the amount reimbursed limits their widespread availability and market penetration, hindering overall market growth.

Global Abdominal Vascular Graft Market Opportunities

Expansion Opportunities in Endovascular Aneurysm Repair (EVAR) for Complex AAA Anatomies

The global abdominal vascular graft market offers significant expansion opportunities within Endovascular Aneurysm Repair (EVAR) specifically targeting complex Abdominal Aortic Aneurysm (AAA) anatomies. Traditionally, many patients with challenging anatomical features like short or angulated necks, or visceral artery involvement, were ineligible for standard EVAR, often necessitating open surgery or remaining untreated.

This unmet clinical need is driving innovation and creating a substantial market opening. The development and adoption of advanced EVAR technologies, such as fenestrated, branched, or custom made devices, are enabling minimally invasive treatment for these previously excluded patient populations. These specialized grafts allow for precise aneurysm sealing while preserving vital branch vessels, making EVAR a viable and safer option for a broader range of complex cases.

Capitalizing on these capabilities expands the eligible patient pool for EVAR, accelerates the shift towards endovascular techniques, and fuels demand for sophisticated grafting systems. This advancement improves patient outcomes by offering less invasive alternatives, thereby significantly enlarging the addressable market for abdominal vascular grafts worldwide.

Increasing Adoption of Minimally Invasive Grafts in Emerging Healthcare Markets

Emerging healthcare markets, particularly in Asia Pacific, offer a significant opportunity for minimally invasive abdominal vascular grafts. As these economies develop, their healthcare systems increasingly prioritize improved patient outcomes and efficiency. Minimally invasive procedures provide substantial advantages over open surgery, including reduced patient trauma, shorter hospital stays, faster recovery, and fewer complications. These benefits are highly attractive in evolving healthcare landscapes, leading to enhanced patient quality of life and potential cost savings for providers. Rising disposable incomes and expanding access to advanced medical treatments further drive patient demand for less invasive options. Manufacturers establishing effective distribution for innovative, high quality, and accessible minimally invasive graft solutions will capitalize on this trend. The move towards patient centricity and modern surgical techniques positions these grafts as a preferred choice for healthcare providers aiming to enhance their services. This adoption surge, driven by both clinical superiority and economic efficiency, represents a lucrative growth area across these developing regions.

Global Abdominal Vascular Graft Market Segmentation Analysis

Key Market Segments

By Type

  • •Endovascular Grafts
  • •Surgical Grafts
  • •Fenestrated Grafts

By Material

  • •Polyester
  • •Polytetrafluoroethylene
  • •Composite Materials

By Application

  • •Aneurysm Repair
  • •Vascular Bypass
  • •Trauma Surgery

By End Use

  • •Hospitals
  • •Ambulatory Surgical Centers
  • •Specialized Clinics

Segment Share By Type

Share, By Type, 2025 (%)

  • Endovascular Grafts
  • Surgical Grafts
  • Fenestrated Grafts
maklogo
$2.85BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why is Aneurysm Repair the leading application in the Global Abdominal Vascular Graft Market?

The dominance of aneurysm repair, holding a significant share, is primarily driven by the increasing prevalence of abdominal aortic aneurysms globally, especially within an aging demographic. Abdominal vascular grafts are critical for preventing life-threatening ruptures, making their application in both elective and emergency aneurysm procedures indispensable. Advances in minimally invasive endovascular repair techniques have further bolstered this segment's growth, offering improved patient outcomes and shorter recovery periods compared to traditional open surgical approaches.

Which material type is commonly employed across various abdominal vascular graft segments?

Polyester stands out as a frequently utilized material for abdominal vascular grafts due to its established biocompatibility, durability, and excellent long-term patency rates. Its mechanical properties allow for robust graft construction, suitable for both surgical and endovascular applications. While polytetrafluoroethylene and composite materials offer specialized benefits, polyester's proven performance and versatility make it a foundational choice for manufacturers catering to diverse needs, from aneurysm repair to vascular bypass procedures.

How do end user facilities influence the adoption and accessibility of abdominal vascular grafts?

Hospitals represent the primary end use segment for abdominal vascular grafts, given their comprehensive infrastructure, specialized surgical departments, and capacity to handle complex vascular procedures and emergencies. While ambulatory surgical centers and specialized clinics are growing in prominence for less complex interventions, hospitals remain crucial for high acuity cases like extensive aneurysm repairs or trauma surgeries requiring immediate, intensive care. Their critical role ensures widespread access to these life-saving devices.

What Regulatory and Policy Factors Shape the Global Abdominal Vascular Graft Market

The global abdominal vascular graft market navigates a complex regulatory landscape characterized by diverse national and regional frameworks. Key bodies like the US Food and Drug Administration, European Medicines Agency, Japan's Pharmaceuticals and Medical Devices Agency, and China's National Medical Products Administration impose rigorous premarket approval requirements. These include comprehensive preclinical testing, extensive clinical trials demonstrating safety and efficacy, and strict adherence to quality management system standards such as ISO 13485. Postmarket surveillance and vigilance requirements mandate continuous monitoring for adverse events and product recalls, fostering ongoing accountability. Evolving regulations, particularly the European Medical Device Regulation, introduce stricter clinical evidence and greater transparency. Furthermore, reimbursement policies by governmental and private insurers significantly influence market access and adoption. Growing emphasis on supply chain integrity and cybersecurity adds layers of compliance. International harmonization efforts, spearheaded by the International Medical Device Regulators Forum, aim to streamline regulatory pathways and reduce redundancies globally, though significant regional variations persist, impacting innovation and market entry strategies.

What New Technologies are Shaping Global Abdominal Vascular Graft Market?

Innovations in the global abdominal vascular graft market are driven by continuous advancements enhancing patient outcomes. Emerging technologies focus on developing next generation grafts with superior biocompatibility and longevity. Significant progress is observed in bioresorbable materials reducing long term complications and allowing natural vessel remodeling. Drug eluting grafts are gaining traction preventing restenosis and improving patency rates. Personalized medicine is impacting graft design through advanced 3D printing techniques enabling custom fit solutions for complex anatomies. Minimally invasive endovascular aneurysm repair remains a key driver with evolving stent graft designs offering enhanced conformability and smaller delivery profiles. Artificial intelligence and advanced imaging are improving surgical planning and intraoperative guidance for precise placement. Cell seeded grafts and tissue engineered solutions represent future frontiers aiming for truly regenerative vascular repair. These innovations collectively aim to expand treatment options improve safety and extend graft durability for patients worldwide.

Global Abdominal Vascular Graft Market Regional Analysis

Global Abdominal Vascular Graft Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
38.7%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

Dominant Region

North America · 38.7% share

North America stands as the dominant region in the global abdominal vascular graft market, commanding a significant 38.7% share. This leadership position is primarily driven by advanced healthcare infrastructure and robust technological adoption within the region. A high prevalence of cardiovascular diseases, particularly abdominal aortic aneurysms, further fuels demand for these crucial medical devices. The presence of key market players and a well-established regulatory framework also contribute to North America's stronghold. Additionally, increased awareness regarding early diagnosis and treatment options among both medical professionals and the general population plays a vital role in sustained market growth and its leading contribution to the global landscape.

Fastest Growing Region

Asia Pacific · 9.2% CAGR

Asia Pacific is poised to be the fastest growing region in the global abdominal vascular graft market, exhibiting a robust compound annual growth rate of 9.2% from 2026 to 2035. This accelerated growth is primarily driven by an increasing geriatric population, a rising prevalence of abdominal aortic aneurysms, and significant improvements in healthcare infrastructure across emerging economies like India and China. Enhanced awareness regarding early diagnosis and treatment options, coupled with a growing number of skilled vascular surgeons, are further propelling market expansion. Furthermore, government initiatives to improve access to advanced medical devices and a burgeoning medical tourism sector contribute substantially to this rapid regional growth. Technological advancements in graft materials and less invasive procedures are also key accelerators.

Top Countries Overview

The U.S. is the largest abdominal vascular graft market globally, driven by an aging population, rising aneurysm prevalence, and high adoption of advanced grafts. Significant R&D and key players characterize the competitive landscape, with continuous innovation in less invasive procedures and improved graft materials. The U.S. heavily influences global market trends and technological advancements.

China plays a crucial role in the global abdominal vascular graft market. Its large patient base and increasing healthcare expenditure drive significant demand. Local manufacturers are emerging, challenging established international players through competitive pricing and expanding product portfolios. While foreign brands still dominate premium segments, domestic companies are rapidly gaining market share, particularly in public hospitals. This dynamic landscape fosters innovation and competition, impacting global market strategies.

India's abdominal vascular graft market, though nascent, is expanding due to rising lifestyle diseases and an aging population. Local manufacturing is limited, creating significant import reliance. Growth drivers include increasing healthcare spending and improved diagnostic capabilities. Challenges involve high procedure costs and lack of widespread surgeon training, hindering market penetration compared to developed economies. This presents opportunities for innovative, cost-effective grafts and training programs.

Impact of Geopolitical and Macroeconomic Factors

Geopolitical tensions, particularly trade disputes between major powers like the US and China, could disrupt medical device supply chains, impacting raw material availability and manufacturing costs for abdominal vascular grafts. Regional conflicts or political instability in key manufacturing hubs might lead to production delays or increased logistics expenses. Moreover, evolving regulatory landscapes in different countries, influenced by national healthcare priorities and technological advancements, create market fragmentation and necessitate localized market entry strategies for graft manufacturers.

Macroeconomic factors significantly influence market dynamics. Inflationary pressures globally are raising manufacturing costs, potentially leading to higher graft prices or squeezing profit margins for companies. Interest rate hikes by central banks could impact investment in R&D for next generation graft technologies. Healthcare budget constraints in various nations, driven by economic slowdowns, might limit hospital procurement of premium grafts. Conversely, growing healthcare expenditures in emerging economies, fueled by rising incomes and expanding access to modern medical treatments, present new market opportunities for abdominal vascular graft companies.

Recent Developments

  • March 2025

    Cardinal Health announced a strategic partnership with Vasorum to enhance the distribution network for next-generation endovascular repair systems. This collaboration aims to broaden the market reach for advanced abdominal vascular grafts, particularly in emerging markets, leveraging Cardinal Health's extensive logistics and sales infrastructure.

  • February 2025

    Gore Medical launched its latest iteration of the GORE® EXCLUDER® AAA Endoprosthesis, featuring an improved stent design for enhanced conformability and long-term durability. This product aims to reduce the incidence of endoleaks and improve patient outcomes in complex abdominal aortic aneurysm repairs.

  • January 2025

    Boston Scientific completed its acquisition of a key technology from Aptus Endosystems, integrating Aptus's innovative endograft fixation system into its existing portfolio. This acquisition strengthens Boston Scientific's position in the abdominal vascular graft market by offering a more comprehensive solution for challenging aneurysm anatomies.

  • April 2025

    Terumo Corporation initiated a large-scale clinical trial for a novel bioresorbable abdominal vascular graft in collaboration with several leading cardiac surgery centers globally. This strategic initiative focuses on evaluating the long-term efficacy and safety of grafts designed to naturally integrate with the patient's anatomy, potentially minimizing the need for permanent implant materials.

  • May 2024

    Cook Medical announced the successful completion of CE Mark approval for its new fenestrated abdominal aortic aneurysm (AAA) endograft system. This approval allows for the commercialization of a custom-made device designed to treat patients with complex AAA anatomies involving visceral arteries, expanding treatment options for a critical patient population in Europe.

Key Players Analysis

The global abdominal vascular graft market is shaped by key players like Gore Medical, Boston Scientific, and Cardinal Health, who are pivotal in developing advanced graft technologies. Companies like Endologix and Cook Medical focus on innovative stent grafts and delivery systems, improving minimally invasive procedures. Strategic initiatives include expanding product portfolios, pursuing mergers and acquisitions, and investing in research and development to address evolving patient needs. Market growth is driven by the increasing prevalence of abdominal aortic aneurysms, an aging population, and technological advancements offering improved patient outcomes and reduced recovery times.

List of Key Companies:

  1. Cardinal Health
  2. Endologix
  3. JOTEC
  4. Cook Medical
  5. Bard Medical
  6. Aptus Endosystems
  7. Gore Medical
  8. Boston Scientific
  9. Vasorum
  10. Terumo Corporation
  11. Cordis
  12. Medtronic
  13. Abbott Laboratories
  14. Maquet
  15. Medtronic Vascular
  16. Svelte Medical System

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 2.85 Billion
Forecast Value (2035)USD 5.12 Billion
CAGR (2026-2035)6.7%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Type:
    • •Endovascular Grafts
    • •Surgical Grafts
    • •Fenestrated Grafts
  • By Material:
    • •Polyester
    • •Polytetrafluoroethylene
    • •Composite Materials
  • By Application:
    • •Aneurysm Repair
    • •Vascular Bypass
    • •Trauma Surgery
  • By End Use:
    • •Hospitals
    • •Ambulatory Surgical Centers
    • •Specialized Clinics
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global Abdominal Vascular Graft Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Type
5.1.1. Endovascular Grafts
5.1.2. Surgical Grafts
5.1.3. Fenestrated Grafts
5.2. Market Analysis, Insights and Forecast, 2020-2035, By Material
5.2.1. Polyester
5.2.2. Polytetrafluoroethylene
5.2.3. Composite Materials
5.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
5.3.1. Aneurysm Repair
5.3.2. Vascular Bypass
5.3.3. Trauma Surgery
5.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
5.4.1. Hospitals
5.4.2. Ambulatory Surgical Centers
5.4.3. Specialized Clinics
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America Abdominal Vascular Graft Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Type
6.1.1. Endovascular Grafts
6.1.2. Surgical Grafts
6.1.3. Fenestrated Grafts
6.2. Market Analysis, Insights and Forecast, 2020-2035, By Material
6.2.1. Polyester
6.2.2. Polytetrafluoroethylene
6.2.3. Composite Materials
6.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
6.3.1. Aneurysm Repair
6.3.2. Vascular Bypass
6.3.3. Trauma Surgery
6.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
6.4.1. Hospitals
6.4.2. Ambulatory Surgical Centers
6.4.3. Specialized Clinics
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe Abdominal Vascular Graft Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Type
7.1.1. Endovascular Grafts
7.1.2. Surgical Grafts
7.1.3. Fenestrated Grafts
7.2. Market Analysis, Insights and Forecast, 2020-2035, By Material
7.2.1. Polyester
7.2.2. Polytetrafluoroethylene
7.2.3. Composite Materials
7.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
7.3.1. Aneurysm Repair
7.3.2. Vascular Bypass
7.3.3. Trauma Surgery
7.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers
7.4.3. Specialized Clinics
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific Abdominal Vascular Graft Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Type
8.1.1. Endovascular Grafts
8.1.2. Surgical Grafts
8.1.3. Fenestrated Grafts
8.2. Market Analysis, Insights and Forecast, 2020-2035, By Material
8.2.1. Polyester
8.2.2. Polytetrafluoroethylene
8.2.3. Composite Materials
8.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
8.3.1. Aneurysm Repair
8.3.2. Vascular Bypass
8.3.3. Trauma Surgery
8.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centers
8.4.3. Specialized Clinics
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America Abdominal Vascular Graft Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Type
9.1.1. Endovascular Grafts
9.1.2. Surgical Grafts
9.1.3. Fenestrated Grafts
9.2. Market Analysis, Insights and Forecast, 2020-2035, By Material
9.2.1. Polyester
9.2.2. Polytetrafluoroethylene
9.2.3. Composite Materials
9.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
9.3.1. Aneurysm Repair
9.3.2. Vascular Bypass
9.3.3. Trauma Surgery
9.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Specialized Clinics
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa Abdominal Vascular Graft Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Type
10.1.1. Endovascular Grafts
10.1.2. Surgical Grafts
10.1.3. Fenestrated Grafts
10.2. Market Analysis, Insights and Forecast, 2020-2035, By Material
10.2.1. Polyester
10.2.2. Polytetrafluoroethylene
10.2.3. Composite Materials
10.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
10.3.1. Aneurysm Repair
10.3.2. Vascular Bypass
10.3.3. Trauma Surgery
10.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Specialized Clinics
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. Cardinal Health
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. Endologix
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. JOTEC
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. Cook Medical
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. Bard Medical
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. Aptus Endosystems
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. Gore Medical
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. Boston Scientific
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. Vasorum
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. Terumo Corporation
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Cordis
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. Medtronic
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis
11.2.13. Abbott Laboratories
11.2.13.1. Business Overview
11.2.13.2. Products Offering
11.2.13.3. Financial Insights (Based on Availability)
11.2.13.4. Company Market Share Analysis
11.2.13.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.13.6. Strategy
11.2.13.7. SWOT Analysis
11.2.14. Maquet
11.2.14.1. Business Overview
11.2.14.2. Products Offering
11.2.14.3. Financial Insights (Based on Availability)
11.2.14.4. Company Market Share Analysis
11.2.14.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.14.6. Strategy
11.2.14.7. SWOT Analysis
11.2.15. Medtronic Vascular
11.2.15.1. Business Overview
11.2.15.2. Products Offering
11.2.15.3. Financial Insights (Based on Availability)
11.2.15.4. Company Market Share Analysis
11.2.15.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.15.6. Strategy
11.2.15.7. SWOT Analysis
11.2.16. Svelte Medical System
11.2.16.1. Business Overview
11.2.16.2. Products Offering
11.2.16.3. Financial Insights (Based on Availability)
11.2.16.4. Company Market Share Analysis
11.2.16.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.16.6. Strategy
11.2.16.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Type, 2020-2035

Table 2: Global Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 3: Global Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 4: Global Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 5: Global Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Type, 2020-2035

Table 7: North America Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 8: North America Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 9: North America Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 10: North America Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Type, 2020-2035

Table 12: Europe Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 13: Europe Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 14: Europe Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 15: Europe Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Type, 2020-2035

Table 17: Asia Pacific Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 18: Asia Pacific Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 19: Asia Pacific Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 20: Asia Pacific Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Type, 2020-2035

Table 22: Latin America Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 23: Latin America Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 24: Latin America Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 25: Latin America Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Type, 2020-2035

Table 27: Middle East & Africa Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 28: Middle East & Africa Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 29: Middle East & Africa Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 30: Middle East & Africa Abdominal Vascular Graft Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

Industry

Healthcare Market Research

Explore comprehensive market research reports covering all aspects of the Healthcare industry, including market size, growth trends, competitive landscape, and strategic insights.

View Industry Page
;